Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Volta Labs, Inc.
AddedFeb 15, 2024
UpdatedJul 3, 2026
Volta Labs, Inc.

Volta Labs, Inc.

Series A

Volta Labs: Revolutionizing genomics with digital fluidics for advanced biological research.

HQ
Cambridge, MA, US
Founded
2018
Accelerator
Y Combinator logoY CombinatorW19
Overview
Compare
Fundraising
Employees
Website

Volta Labs, Inc. is a genomics applications company dedicated to unlocking the utility of genomics for the world. The company has developed an innovative digital fluidics platform designed to enhance the performance and scalability of sample preparation in genomics, ensuring unparalleled consistency. This technology transforms biological research and analyses, enabling scientists to focus on advancing the boundaries of biology. Volta Labs operates at the intersection of engineering and biology, offering push-button sample preparation compatible with any sequencer.

Volta Labs has made significant strides in the genomics field, notably unveiling their digital fluidics technology at the Advances in Genome Biology and Technology (AGBT) conference. Their platform leverages electrowetting for automated next-generation sequencing (NGS), showcasing their commitment to innovation and automation in genomics research. Through these advancements, Volta Labs is making a substantial impact on the efficiency and accuracy of genomic studies, contributing to the broader scientific community's efforts to understand and utilize genetic information.

Volta Labs, Inc. - Similar Companies

Inscripta logo

Inscripta

inscripta.com

WhiteLab Genomics logo

WhiteLab Genomics

whitelabgx.com

Singular Genomics logo

Singular Genomics

XGenomes logo

XGenomes

xgenomes.com

Streamline Genomics logo

Streamline Genomics

Via Scientific logo

Via Scientific

viascientific.com

MicroPure Genomics logo

MicroPure Genomics

Nest Genomics logo

Nest Genomics

nestgenomics.com

Sequegenics logo

Sequegenics

sequegenics.com

Scispot logo

Scispot

scispot.io

Aqueduct Fluidics logo

Aqueduct Fluidics

Ovation logo

Ovation

ovation.io

Flexomics logo

Flexomics

flexomics.com

Ginkgo Bioworks logo

Ginkgo Bioworks

ginkgobioworks.com

Lamin logo

Lamin

lamin.ai

Volta Labs, Inc. - Quick Facts

Who are Volta Labs, Inc.'s competitors?

Companies similar to Volta Labs, Inc. include Inscripta, WhiteLab Genomics, Singular Genomics and XGenomes.

When was Volta Labs, Inc. founded?

Volta Labs, Inc. was founded in 2018.

Where is Volta Labs, Inc.'s headquarters located?

Volta Labs, Inc.'s headquarters is located in Cambridge, MA, US.

When was Volta Labs, Inc.'s last funding round?

Volta Labs, Inc.'s most recent funding round was for $4.3M (USD) in January 2024.

How much has Volta Labs, Inc. raised to-date?

As of Jan 12, 2024, Volta Labs, Inc. has raised a total of $24.4M (USD).

How many employees does Volta Labs, Inc. have?

Volta Labs, Inc. has 50 employees as of Apr 28, 2024.

Volta Labs, Inc. - Classification

Ownership
  • Venture Capital
Technology
  • Automation
  • Robotics
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Genomics
  • Sample Prep
Tags
  • API
  • Biotech
  • Research
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 541700Scientific Research and Development Services
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research